Slide 1: Q4 2024 Earnings Call
Q4 2024 EARNINGS CALL MARCH 5, 2025
Slide 2: Cautionary Statements
Cautionary Statements Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other
Slide 3: Puneet Khanna, President and Chief Executive Officer
PUNEET KHANNA PRESIDENT AND CHIEF EXECUTIVE OFFICER 3
Slide 4: Q4 2024 Highlights
Q4 2024 • Revenue in Q4 2024 of $92.2 million • Adjusted EBITDA in Q4 2024 of $7.6 million • Appointed new Chief Financial Officer • Announced new state-of-the-art pharmacy in British Columbia • Announced final conversion of convertible debentures 4
Slide 5: Suzanne Brand, Chief Financial Officer
SUZANNE BRAND CHIEF FINANCIAL OFFICER 5
Slide 6: Financial Results | Revenue
Q4 2024 Financial Results | Revenue (millions) 110 100 $91.1 $92.8 $92.2 90 • Average beds serviced of 87,658: -4.2% vs Q4 2023 80 70 • Year-over-year revenue increase primarily driven 60 by an increase in branded pharmaceutical prices 50 during the third quarter of 2024, despite lower year-over-yea
Slide 7: Financial Results | Adjusted EBITDA
Q4 2024 Financial Results | Adjusted EBITDA (millions) 10 9 $7.5 $7.8 $7.6 • Year-over-year increase in Adjusted EBITDA 8 primarily the result of certain efficiencies and 7 cost savings initiatives that commenced 6 during 2H 2023 as well as improved supply terms from amended procurement agreement 5
Slide 8: Financial Results | Net Income
Q4 2024 Financial Results | Net Income (millions) Q4 2023 Q3 2024 Q4 2024 2 • Decrease in net loss driven primarily by decreases 1 in finance costs in addition to the impact of certain cost savings initiatives that commenced 0 during the second half of 2023, partially offset by an increase in share-
Slide 9: Balance Sheet
Balance Sheet (millions except ratio) At Dec 31/24 • Quarter-over-quarter increase in cash balance and decline in net debt due to increase in cash flow from operations and repayment of convertible debentures Cash $9.1 M and operating loan Net Debt $36.2M • Total debt reduced by $21.8 million year-ov
Slide 10: Puneet Khanna, President and Chief Executive Officer
PUNEET KHANNA PRESIDENT AND CHIEF EXECUTIVE OFFICER 10
Slide 11: New State-of-the-Art Pharmacy in North Burnaby
New State-of-the-Art Pharmacy in North Burnaby • Opened new high-volume fulfillment centre in North Burnaby, British Columbia in December 2024 • Advanced high-volume medication packaging technology, optimized workflows and streamlined operations • Designed to enhance service delivery for the homes a
Slide 12: Growth Strategy
Growth Strategy Organic Bed Wins • Leverage scale & capabilities to provide superior pharmacy services offering • Robust sales and RFP pipeline Existing Partners • Large national and regional customers continue Growth to acquire smaller competitors New Home • Home operators expanding through increas
Slide 13: Shaping the Future of Senior Care
wee SHAPING THE FUTURE OF SENIOR CARE